Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lund
Clinical trial register · Sweden

Clinical Trials in Lund, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2214 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:17 UTC
2214
Studies in scope
all four open statuses
1237
Recruiting now
open to new participants
362
Lead sponsors
across recruiting studies
Top sites
Stockholm 925 Gothenburg 632 Lund 405 Uppsala 368 Malmö 237
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Region Skane66 Lund University22 AstraZeneca21 Karolinska Institutet13 Janssen Research & Development, LLC12 Lund University Hospital11 Merck Sharp & Dohme LLC10 Vastra Gotaland Region8 Skane University Hospital8 Amgen6 Bayer6 Novartis Pharmaceuticals6 Uppsala University6 Bristol-Myers Squibb5 AbbVie5 Stichting Hemato-Oncologie voor Volwassenen Nederland5 Sanofi5 BioInvent International AB4 Celgene4 Peter Siesjö4 Malmö University3 Takeda3 Sahlgrenska University Hospital3 Ribocure Pharmaceuticals AB3 Linkoeping University3 Boehringer Ingelheim3 Genmab3 Oslo University Hospital3 GlaxoSmithKline3 Pfizer3 Karolinska University Hospital3 Hoffmann-La Roche2 Medtronic Cardiovascular2 Daniel Lindqvist2 BeOne Medicines2 Novo Nordisk A/S2 Helsinki University Central Hospital2 Nordic Lymphoma Group2 BioNTech SE2 Actelion2 Daiichi Sankyo2 Gustave Roussy, Cancer Campus, Grand Paris2 Incyte Corporation2 Göteborg University2 Medtronic2 Region Örebro County2 University Hospital Muenster2 Region Stockholm2 Norwegian University of Science and Technology2 Copenhagen University Hospital, Rigshospitalet2 Mats Heyman2 Acorai AB2 Uppsala University Hospital2 Alexion Pharmaceuticals, Inc.2 Aarhus University Hospital2 Cogent Biosciences, Inc.1 SynOx Therapeutics Limited1 Immunocore Ltd1 University of Helsinki1 OHB Neonatology Ltd.1 Zimmer Biomet1 Hildur Helgadottir1 Thomas Engstrom1 Lars Olaf Cardell1 Kenny Rodriguez-Wallberg1 European Myeloma Network B.V.1 Neurocrine Biosciences1 Vertex Pharmaceuticals Incorporated1 Elin Tragardh1 Medstar Health Research Institute1 taVNS AB1 Kyowa Kirin Pharmaceutical Development Ltd1 The Hospital for Sick Children1 Aarhus University Hospital Skejby1 Blekinge County Council Hospital1 Exelixis1 Britannia Pharmaceuticals Ltd.1 Alnylam Pharmaceuticals1 Jon Unosson1 Fore Biotherapeutics1 EP Solutions SA1 Philips Clinical & Medical Affairs Global1 Boston Scientific Corporation1 St. Anna Kinderkrebsforschung1 Ersta Diakoni1 VDyne, Inc.1 AGO Study Group1 CytoSorbents, Inc1 European Organisation for Research and Treatment of Cancer - EORTC1 Karin Soderkvist1 Loxo Oncology, Inc.1 Guri Hagberg1 St George's, University of London1 Thomas Kander1 The Leeds Teaching Hospitals NHS Trust1 University of Aarhus1 Magnus Nilsson1 Ole Frobert, MD, PhD1 Halmstad County Hospital1 Stichting European Myeloma Network1 Raija Silvennoinen1 Acerta Pharma BV1 Princess Maxima Center for Pediatric Oncology1 Tesaro, Inc.1 Åslaug Helland1 Kirsten Grønbæk1 Erasmus Medical Center1 Alexander Valdman1 COMPASS Pathways1 pharmaand GmbH1 International Extranodal Lymphoma Study Group (IELSG)1 University of Dublin, Trinity College1 AviadoBio Ltd1 Eli Lilly and Company1 Centre Leon Berard1 Eva Marie Erfurth, MD, PhD1 M.D. Anderson Cancer Center1 Queen Silvia Children's Hospital, Gothenburg, Sweden1 Elixir Medical Corporation1 Danish Breast Cancer Cooperative Group1 UNICANCER1 Biotronik AG1 German CLL Study Group1 Daniel Wilhelms1 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 BeiGene1 Children's Oncology Group1 Niguarda Hospital1 Day One Biopharmaceuticals, Inc.1 Thomas Hatschek1 Oulu University Hospital1 Oticon Medical1 Navamedic AB1 AO Innovation Translation Center1 Heinrich-Heine University, Duesseldorf1 Diagram B.V.1 MedImmune LLC1 Herlev Hospital1 Lina Bergman1 Eva Ekvall-Hansson1 Jeanette Lundin1 Swedish Orphan Biovitrum1 Medical University of Vienna1 Pharvaris Netherlands B.V.1 University Hospital, Basel, Switzerland1 Umeå University1 Region Västerbotten1 Sahar Salehi1 Malin Eleonora av Kák Gustafsson, MD, PhD1 Xinnate AB1 Population Health Research Institute1 Aalborg University Hospital1
Site location
Stockholm925 Gothenburg632 Lund405 Uppsala368 Malmö237 Linköping230 Umeå194 Örebro189 Solna111 Falun75 Huddinge74 Jönköping70 Helsingborg56 Gävle53 Borås48 Mölndal41 Karlstad41 Kalmar37 Västerås34 Halmstad34 Luleå30 Skövde28 Karlskrona27 Sundsvall25 Eskilstuna25 Vaxjo23 Uddevalla20 Norrköping20 Danderyd19 Kristianstad17 Alingsås16 Östersund15 Hässleholm13 Eksjö9 Skellefteå9 Skåne7 Lidköping7 Södertälje7 Kungsbacka7 Trollhättan6 Multiple Locations6 Kungälv6 Gällivare5 Mora5 Varberg5 Motala5 Ängelholm5 Enköping5 Lycksele4 Norrtälje4 Ystad4 Ljungby4 Rättvik4 Karlskoga4 Mölnlycke4 Trelleborg4 Many Locations3 Södra Sunderbyn3 Hudiksvall3 Vänersborg3 Nacka2 Ulricehamn2 Lindesberg2 Värnamo2 Upplands Vasby2 Borlänge2 Stockholm - Huddinge2 Angered2 Flen2 Gustavsberg2 Finspång2 Hemse2 Allingsas2 Haninge1 Styrsö1 Boxholm1 Vallentuna1 Uppasala1 Huskvarna1 Sollefteå1 Våxtorp1 Lidingö1 Stenungsund1 Bergshamra1 Skara1 Jonsered1 Visby1 Avesta1 Mlndal1 Molndahl1 Örnsköldsvik1 Nyköping1 Bollebygd1 Dalsjöfors1 Falköping1 Gråbo1 Kållekärr1 Arvika1 Johanneshov1 Kalix1 Saltsjö-Boo1 Eslöv1 Simrishamn1 Sjöbo1 Gasteborg1 Älvsjö1 Leksand1 Vasterbottens Lan1 Bäckefors1 Bollnäs1 Katrineholm1 Saltsjöbaden1 Västra Frölunda1 Stockholms1 Hålland1 Landskrona1 Göteborg1 Höllviken1 Torsby1 Luelå1 Nörrköping1 Mjölby1 Linkoping1 Henån1 Vårgårda1 Ytterby1 Göteborg1 Skellefte1 Hörby1 Borgholm1 Göthenburg1 Umeå and Skellefteå1 Umeå, Skellefteå, and Lycksele1 Örnsköldsvik and Sundsvall1 Åsele1 Storuman1 Västervik1 Tierp1 Göteburg1 Frölunda1 J0nkoping1 Öre1 Strängnäs1
All 143 locations
Target enrolment
to

Trials with a site in Lund

405 of 2214 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Not yet open
Standalone Thoracoscopic Left Atrial Appendage Closure Versus Medical Therapy in Atrial Fibrillation
NCT07705282ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Oral Anticoagulation, Thoracotomy
Region Skane
Not applicable
936
Lund
2028-01-01
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Skellefte, Lund, Gothenburg, Stockholm
2027-11-23
Not yet open
Aalborg University Hospital
Not applicable
32
Lund
2027-01
Not yet open
Sahlgrenska University Hospital
Phase 4
400
Gothenburg, Falun, Jönköping, Lund, Malmö, Mölndal, Norrtälje, Skövde
2026-12-01
Not yet open
Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) With Atorvastatin (ATORGO)
NCT07883356Graves Disease, Graves Disease (Basedow's Disease), Graves Orbitopathy, Graves Ophthalmopathy
DrugAtorvastatin
Region Skane
Phase 2
554
Gothenburg, Lund, Malmö, Örebro, Stockholm, Umeå, Uppsala
2026-11-01
Not yet open
RBD1119 in Coronary Artery Disease (CAD)
NCT07884136Stable Coronary Artery Disease
DrugRBD1119
Ribocure Pharmaceuticals AB
Phase 2
200
Lund, Mölndal, Örebro, Rättvik, Stockholm
2026-10-16
Recruiting
Effects of Microelectrode-based Brain Stimulation in Humans
NCT07820189Essential Tremor, Parkinsons Disease (PD)
Lund University
Not applicable
12
Lund
2026-10-15
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
NCT07871864Osteosarcoma, Pediatric Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
530
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2026-10-07
Not yet open
Vortosiran in Atrial Fibrillation
NCT07870889Non-valvular Atrial Fibrillation (AF)
DrugsVortosiran·Apixaban
Ribocure Pharmaceuticals AB
Phase 2
150
Danderyd, Lund, Stockholm
2026-10-01
Recruiting
Copenhagen University Hospital, Rigshospitalet
Not applicable
1,986
Lund
2026-10-01
Recruiting
Daniel Lindqvist
Phase 3
126
Lund
2026-10
Not yet open
Region Skane
Observational
40
Lund
2026-09-21
Active, closed
Predictive Biomarkers for Precision Management of Pre-cancerous Cervical Neoplasia
NCT07895641HSIL, High Grade Squamous Intraepithelial Lesion, DNA Methylation, CIN - Cervical Intraepithelial Neoplasia
Lund University
Observational
199
Lund
2026-09-19
Not yet open
REcovery After Cancer Application
NCT07642492Oesophageal Cancer, Gastric Cancer (Diagnosis)
Karolinska Institutet
Not applicable
250
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2026-09-15
Recruiting
Takeda
Phase 3
324
Lund, Örebro, Stockholm
2026-09-10
Recruiting
Acorai AB
Observational
392
Lund
2026-09-01
Recruiting
Skane University Hospital
Not applicable
10
Lund
2026-09-01
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Gothenburg, Jönköping, Karlstad, Lund, Mölndal, Örebro, Stockholm, Uppsala
2026-08-24
Recruiting
AstraZeneca
Phase 3
500
Linköping, Lund, Mölndal, Örebro, Stockholm
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Falun, Gothenburg, Karlstad, Linköping, Lund, Örebro, Stockholm, Uppsala
2026-08-21
Recruiting
Novo Nordisk A/S
Phase 3
285
Lund, Mölndal, Örebro, Rättvik
2026-08-04
Recruiting
Karolinska Institutet
Phase 4
40
Lund, Trelleborg
2026-08-01
Active, closed
UNICANCER
Phase 3
2,450
Gothenburg, Lund, Stockholm, Uppsala
2026-07-20
Recruiting
Region Skane
Phase 2
40
Lund
2026-07-20
Recruiting
Boehringer Ingelheim
Phase 3
390
Gothenburg, Lund, Uppsala
2026-07-10
Recruiting
Janssen Research & Development, LLC
Phase 2
230
Falun, Gothenburg, Lund, Stockholm, Uppsala
2026-06-30
Recruiting
AstraZeneca
Phase 3
750
Gothenburg, Huddinge, Lund
2026-06-26
Active, closed
AstraZeneca
Phase 2
326
Gothenburg, Lund, Stockholm, Uppsala
2026-06-11
Recruiting
Region Skane
Not applicable
200
Lund
2026-06-01
Recruiting
Bayer
Phase 3
117
Lund
2026-06-01
Recruiting
Navamedic AB
Phase 4
58
Stockholm, Uppsala, Gothenburg, Lund
2026-05-25
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Gothenburg, Lund, Stockholm
2026-05-11
Recruiting
Region Skane
Phase 2
20
Karlskrona, Lund
2026-05-07
Recruiting
Region Skane
Not applicable
1,300
Gothenburg, Linköping, Lund, Örebro, Stockholm
2026-05-06
Recruiting
ClusterVAP: Multicentre Proteomic Endotyping of Ventilator-associated Pneumonia
NCT07245888Ventilator Acquired Pneumonia, Mechanical Ventilation Complication
Region Skane
Observational
400
Lund, Stockholm
2026-05-01
Recruiting
Region Skane
Phase 2
20
Karlskrona, Lund
2026-04-13
Recruiting
Incyte Corporation
Phase 3
588
Linköping, Lund, Stockholm
2026-04-09
Recruiting
Selenium Intervention Registry Randomized Trial in Heart Failure
NCT07543562Heart Failure, Heart Failure and Reduced Ejection Fraction, Heart Failure and Mildly Reduced Ejection Fraction, Heart Failure and Preserved Ejection Fraction
Skane University Hospital
Phase 3
4,326
Malmö, Gothenburg, Jönköping, Linköping, Lund, Örebro, Stockholm, Umeå
2026-04-01
Recruiting
Non-Invasive Hemodynamic Monitoring in Hospitalized Heart Failure
NCT07671742Heart Failure, Heart Failure Hospitalization, Heart Failure (HF)
Acorai AB
Observational
1,000
Lund
2026-04-01
Recruiting
Skane University Hospital
Not applicable
10
Lund
2026-04-01
Not yet open
Simplified Exercise-based Risk Assessment in Lung Cancer
NCT07506889Lung Cancer (Diagnosis), Lobectomy, Surgery Complications, Neoadjuvant Chemoimmunotherapy
Linkoeping University
Observational
500
Jönköping, Kalmar, Karlskrona, Linköping, Lund
2026-04-01
Recruiting
Sleep and Stroke Rehabilitation Study
NCT07579871Stroke, Sleep Apnea Syndrome (OSAS), Insomnia, Excessive Daytime Sleepiness
Malin Eleonora av Kák Gustafsson, MD, PhD
Observational
226
Lund
2026-03-18
Active, closed
Daniel Lindqvist
Phase 2
12
Lund
2026-03-13
Recruiting
Region Skane
Not applicable
300
Lund, Örebro
2026-03-02
Recruiting
Uppsala University
Observational
2,000
Gothenburg, Lund, Stockholm, Uppsala
2026-03-01
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Lund
2026-03-01
Recruiting
Boehringer Ingelheim
Phase 3
286
Linköping, Lund, Stockholm, Uppsala
2026-02-16
Recruiting
Eli Lilly and Company
Phase 3
300
Lund, Örebro, Östersund, Stockholm, Uddevalla
2026-02-05
Recruiting
Virtual Planning of Total Temporomandibular Joint Replacement
NCT07373184Temporomandibular Disorders (TMD), Temporomandibular Joint Ankylosis
Lund University Hospital
Observational
30
Lund
2026-02-01
Not yet open
Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis
NCT07413081Cardiac Amyloidosis, Pacemaker
Region Skane
Not applicable
34
Gothenburg, Linköping, Lund, Skellefteå, Stockholm, Umeå, Uppsala
2026-02-01
Recruiting
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
NCT06594393Epidermolysis Bullosa (EB), Dystrophic Epidermolysis Bullosa, Junctional Epidermolysis Bullosa
Xinnate AB
Phase 2
32
Lund, Uppsala
2026-01-30
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Lund, Stockholm, Linköping
2026-01-19
Recruiting
Uppsala University
Not applicable
200
Gothenburg, Lund, Stockholm, Uppsala
2026-01-09
Active, closed
COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)
NCT07455097Intermediate-risk Prostate Cancer, High-risk Prostate Cancer
Heinrich-Heine University, Duesseldorf
Observational
600
Lund
2026-01-01
Recruiting
Evaluation of a Family-centered Program for Problematic Gaming/Excessive Screen Use
NCT07245862Adolescent Behavior, Social Media Addiction, Gaming Disorder, Family Relations
Region Skane
Not applicable
170
Lund
2026-01-01
Recruiting
AstraZeneca
Phase 3
1,100
Linköping, Lund, Solna, Umeå, Uppsala
2025-12-29
Recruiting
European Myeloma Network B.V.
Phase 3
1,000
Lund
2025-12-23
Recruiting
AstraZeneca
Phase 2
230
Helsingborg, Lund, Malmö, Västerås
2025-12-10
Recruiting
Febrile Infants Swedish Study
NCT07134751Febrile Illness Acute, Meningitis, Bacterial, Urinary Tract Infection (Diagnosis), Invasive Bacterial Infection
Region Skane
Observational
2,000
Gothenburg, Helsingborg, Jönköping, Kristianstad, Lund, Malmö, Örebro, Stockholm
2025-12-01
Recruiting
Region Skane
Observational
40
Lund
2025-12-01
Recruiting
Uppsala University
Phase 4
560
Borås, Eskilstuna, Gothenburg, Karlskrona, Lund, Örebro, Stockholm, Sundsvall
2025-12
Recruiting
Aarhus University Hospital
Phase 3
1,652
Lund
2025-11-26
By invitation
Linkoeping University
Not applicable
120
Gothenburg, Helsingborg, Kalmar, Linköping, Lund, Motala, Norrköping, Stockholm
2025-11-20
Recruiting
Bayer
Phase 3
111
Lund
2025-11-19
Recruiting
Lund University
Not applicable
60
Lund
2025-11-10
Recruiting
Magnus Nilsson
Phase 3
262
Gothenburg, Lund, Örebro, Stockholm, Uppsala
2025-11-05
Recruiting
Study on Orthosis in Cervical Spine Fracture Treatment
NCT06848660Cervical Spine Fractures, Cervical Spine Injury, Rigid Collar
Uppsala University Hospital
Not applicable
616
Gothenburg, Linköping, Lund, Malmö, Umeå, Uppsala
2025-11-01
By invitation
UPSIDES - Recovery Through Peer Support
NCT07407842Mental Illness
Lund University
Not applicable
300
Lund
2025-11-01
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Lund, Stockholm, Uppsala, Gothenburg
2025-10-23
Recruiting
GlaxoSmithKline
Phase 1/2
47
Lund, Stockholm, Uppsala
2025-10-20
Not yet open
Eva Ekvall-Hansson
Observational
50
Lund
2025-10-15
Recruiting
Bristol-Myers Squibb
Observational
223
Lund, Solna, Örebro
2025-10-08
Recruiting
Region Skane
Not applicable
8,000
Helsingborg, Kristianstad, Lund, Malmö
2025-10-01
Recruiting
Manual Lymph Drainage for External Lymphedema
NCT07215169Lymphedema of Face, Neoplasms, Radiotherapy Side Effect, Lymphedema Due to Radiation
Lund University
Not applicable
40
Lund
2025-10-01
Recruiting
Sanofi
Phase 4
218
Gothenburg, Lund
2025-09-22
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Lund, Borås, Uppsala
2025-09-22
Recruiting
Sustained Cord Circulation at Emergency Cesarean Section
NCT06540222Asphyxia Neonatorum, Fetal Hypoxia
Region Skane
Not applicable
2,200
Gothenburg, Halmstad, Linköping, Lund, Malmö, Örebro, Stockholm, Umeå
2025-09-08
Recruiting
Heart-Lung Machine: Impact of the Priming Solution on Acid-Base Balance, Electrolytes and Outcome on Patients Undergoing Cardiac Surgery
NCT07267546Acid Base Imbalance, Osmolality Disturbance, Crystalloid Solutions, Electrolyte Changes
Region Skane
Not applicable
80
Lund
2025-09-01
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Gothenburg, Lund, Stockholm, Uppsala
2025-08-05
Recruiting
Harmony TPV EMEA PMS
NCT06906926Severe Pulmonary Valve Regurgitation
Medtronic Cardiovascular
Not applicable
80
Lund
2025-07-30
Active, closed
Amgen
Phase 3
12,800
Falun, Gothenburg, Helsingborg, Linköping, Lund, Örebro, Stockholm
2025-07-25
Recruiting
Hildur Helgadottir
Phase 3
128
Gothenburg, Lund, Stockholm
2025-07-10
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Gothenburg, Lund, Solna
2025-07-02
Recruiting
Lund University
Not applicable
200
Lund
2025-06-30
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Falun, Gothenburg, Helsingborg, Lund, Norrköping, Solna, Stockholm
2025-06-25
Recruiting
GlaxoSmithKline
Phase 3
981
Lund, Stockholm
2025-06-20
Recruiting
Stepped Versus Stratified Care for Anxiety Disorders in Youth
NCT06942429Social Anxiety Disorder, Separation Anxiety Disorder, Specific Phobia, Panic Disorder
Region Skane
Not applicable
556
Lund
2025-06-19
Recruiting
GlaxoSmithKline
Phase 1/2
346
Gothenburg, Lund, Stockholm, Uppsala
2025-06-11
Recruiting
BeOne Medicines
Phase 3
630
Gothenburg, Lund, Stockholm, Uppsala
2025-06-11
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Gothenburg, Linköping, Lund, Stockholm, Uppsala
2025-06-10
Recruiting
BioNTech SE
Phase 3
480
Lund, Stockholm, Uppsala
2025-06-10
Active, closed
Incyte Corporation
Phase 3
9
Gothenburg, Lund, Stockholm, Uppsala
2025-06-04
Recruiting
AstraZeneca
Phase 3
15,100
Alingsås, Falun, Huddinge, Lidköping, Lund, Östersund, Stockholm, Umeå
2025-06-04
Recruiting
Long-term Follow-up of Depressive Disorders in Psychiatric Care
NCT07078227Depression, Psychiatric Diagnosis, Personality Disorders, Suicide, Attempted
Region Skane
Observational
415
Lund
2025-06-01
Active, closed
Region Skane
Observational
682
Lund
2025-05-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Lund, Uppsala
2025-05-22
Recruiting
Region Skane
Observational
150
Kristianstad, Lund
2025-05-15
Recruiting
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
NCT06793410Recipients of Allogeneic Stem Cell Transplantation, HPV (Human Papillomavirus)-Associated, Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Vastra Gotaland Region
Phase 2
100
Lund, Stockholm, Uppsala, Linköping, Gothenburg
2025-05-12
Recruiting
Oticon Medical
Observational
270
Luleå, Lund
2025-05-07
Recruiting
Takeda
Phase 3
225
Örebro, Huddinge, Gothenburg, Lund
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Gothenburg, Lund, Stockholm, Uppsala
2025-05-05
Not yet open
Region Örebro County
Phase 3
3,832
Visby, Eskilstuna, Falun, Gävle, Gothenburg, Jönköping, Kalmar, Lund
2025-05-02
Recruiting
Exercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study
NCT07025694Children With Cerebral Palsy Who Are Ambulant, Cerebral Palsy GMFCS-ER I-II
Lund University
Not applicable
20
Lund
2025-05-01
Recruiting
Region Skane
Observational
1,500
Lund, Gothenburg
2025-04-28
Recruiting
Neurocrine Biosciences
Phase 3
850
Gothenburg, Lund, Stockholm
2025-04-16
Recruiting
Karolinska Institutet
Phase 4
212
Falun, Gothenburg, Linköping, Lund, Malmö, Nörrköping, Örebro, Stockholm
2025-04-08
Recruiting
Sahlgrenska University Hospital
Observational
220
Gothenburg, Linköping, Luleå, Lund, Örebro, Stockholm, Uppsala
2025-04-01
Recruiting
AstraZeneca
Phase 3
600
Linköping, Lund, Stockholm, Uppsala
2025-03-27
Recruiting
AstraZeneca
Phase 3
990
Gothenburg, Karlskrona, Lund, Örebro, Stockholm
2025-03-25
Recruiting
taVNS AB
Not applicable
128
Lund, Malmö, Örebro, Stockholm, Umeå
2025-03-21
Recruiting
Daiichi Sankyo
Phase 3
582
Lund, Solna, Uppsala
2025-03-19
Recruiting
Thrombolysis in Factor Xa-inhibitors Trial
NCT06878066Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke, Acute Ischemic Stroke
DrugsAlteplase·Tenecteplase
Guri Hagberg
Phase 3
300
Stockholm, Lund, Malmö, Umeå, Uppsala
2025-03-14
Recruiting
AstraZeneca
Phase 3
11,300
Gothenburg, Helsingborg, Huddinge, Lund, Mölndal, Norrköping, Stockholm, Uppsala
2025-03-14
Active, closed
Celgene
Phase 3
960
Lund, Solna, Uppsala, Gothenburg
2025-03-13
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Gothenburg, Huddinge, Lund
2025-03-12
Recruiting
Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia
NCT06726395Staphylococcus Aureus Bacteraemia, Staphylococcal Bacteraemia, Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia), Staphylococcus (S.) Aureus Infection
DrugsCloxacillin·Benzylpenicillin
Region Skane
Phase 4
420
Lund
2025-03-10
Recruiting
Malmö University
Not applicable
66
Lund, Malmö
2025-03-07
Active, closed
Swedish Orphan Biovitrum
Phase 3
89
Gothenburg, Lund, Stockholm
2025-03-06
Recruiting
Lund University
Not applicable
30
Lund
2025-03-05
Active, closed
Sanofi
Phase 3
231
Lund, Solna, Stockholm
2025-02-12
Recruiting
Prolonged Chest Tube Treatment to Reduce Rates of Atrial Fibrillation Following Cardiac Surgery
NCT06800781Coronary Arterial Disease (CAD), Valve Replacement, Aortic Surgery
Region Skane
Not applicable
624
Lund
2025-02-10
Active, closed
The Leeds Teaching Hospitals NHS Trust
Observational
550
Gothenburg, Lund, Uppsala
2025-02-04
Recruiting
3D Versus 2D Strain Echocardiography for Early Detection of Cardiotoxicity During Cancer Therapy
NCT07916337Cancer Related Cardiovascular Toxicity, Anthracycline Related Cardiotoxicity in Breast Cancer, Breast Cancer, Cardiotoxicity
Region Skane
Observational
130
Lund
2025-02-03
Recruiting
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
NCT06419946Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma
DrugsLomustine·Temozolomide
Vastra Gotaland Region
Phase 3
200
Gävle, Gothenburg, Jönköping, Kalmar, Lund, Örebro, Stockholm, Sundsvall
2025-02-01
Recruiting
Ribocure Pharmaceuticals AB
Phase 2
120
Lund, Mölndal, Stockholm, Uppsala
2025-01-28
By invitation
The Skin Microbiota in Skin Disease and Eczema
NCT06924333Skin Disease, Eczema, Eczema Atopic Dermatitis
Region Skane
Observational
100
Lund
2025-01-20
Recruiting
Thomas Kander
Observational
75
Lund
2025-01-16
By invitation
Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
NCT06763783Systemic Vasculitis, Spondylarthropathies, Psoriatic Arthritis, Scleroderma
DrugShingrix
Region Skane
Phase 4
240
Lund
2024-12-17
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Gothenburg, Lund, Stockholm, Uppsala
2024-12-12
Recruiting
Region Skane
Not applicable
150
Lund
2024-12-10
Active, closed
Amgen
Phase 3
707
Gothenburg, Lund, Stockholm, Umeå
2024-12-09
Recruiting
Breath-holding Spells and Its Management Study
NCT06628271Breath-holding Spell
Region Skane
Not applicable
120
Eslöv, Kristianstad, Lund, Malmö, Simrishamn, Sjöbo, Ystad
2024-12-02
Active, closed
AbbVie
Observational
1,314
Huddinge, Stockholm, Lund
2024-11-26
Recruiting
ICBT for OCD in Children With Autism
NCT06582225Obsessive-Compulsive Disorder, Autism Spectrum Disorder
Karolinska Institutet
Not applicable
220
Lund, Gothenburg, Stockholm
2024-11-25
Recruiting
Processed EEG for Monitoring of Anesthetic Depth in Intracranial Tumor Surgery
NCT06922500Brain Tumor Adult, Processed EEG, Total Intravenous Anesthesia
Region Skane
Not applicable
126
Lund
2024-11-21
Active, closed
Daiichi Sankyo
Phase 3
700
Gasteborg, Lund, Uppsala
2024-11-19
Recruiting
Light in Healthcare Environment (Ljus i sjukhusmiljö)
NCT06687304Sleep Quality, Well-being, Melatonin, Cortisol
Lund University
Not applicable
18
Lund, Malmö, Trelleborg
2024-11-15
Recruiting
Lund University
Not applicable
60
Lund
2024-11-12
Recruiting
Region Skane
Observational
10
Lund
2024-11-11
Active, closed
Amgen
Phase 2
409
Gothenburg, Lund, Örebro, Stockholm
2024-11-07
Active, closed
Sanofi
Phase 2
556
Lund
2024-11-07
Recruiting
Promoting Children's Participation in Conventional X-ray Examinations
NCT06322264Heart Rate Determination, Patient Participation
Lund University
Observational
220
Lund
2024-11-05
Recruiting
Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
NCT06578234Chronic Coronary Syndrome, Coronary Artery Disease, Ischemic Heart Disease
DrugAdenosine
Region Skane
Phase 4
180
Lund
2024-10-23
By invitation
Visual and Auditory Distraction for the Relief of Pain and Anxiety
NCT07023692Bone Marrow Aspiration, Pain, Anxiety, Hematologic Diseases
Region Skane
Not applicable
250
Lund
2024-10-20
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Gothenburg, Lund, Stockholm, Uppsala
2024-10-18
Active, closed
SynOx Therapeutics Limited
Phase 3
128
Lund
2024-10-09
Recruiting
Peter Siesjö
Phase 2
10
Lund
2024-10-07
Recruiting
Prevention of Pulmonary Complications After Laparoscopic Liver Surgery
NCT07192575Liver Surgery, Pulmonary Complications, Laparoscopic Liver Surgery
Oulu University Hospital
Not applicable
364
Linköping, Lund
2024-09-15
Recruiting
Stroke Alarm Efficacy Trial
NCT06315192Stroke Acute, Atrial Fibrillation, TIA
Region Skane
Not applicable
500
Gothenburg, Hässleholm, Helsingborg, Huddinge, Linköping, Lund, Malmö, Stockholm
2024-09-05
By invitation
Blekinge County Council Hospital
Observational
200
Karlskrona, Kungsbacka, Ljungby, Lund
2024-09-01
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Danderyd, Gothenburg, Linköping, Lund, Stockholm, Sundsvall, Uppsala
2024-08-30
Recruiting
Bayer
Phase 3
444
Umeå, Lund
2024-08-28
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Lund, Mölndal, Stockholm, Uppsala
2024-07-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Lund, Stockholm, Uppsala, Linköping
2024-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Lund, Huddinge, Uppsala, Gothenburg, Örebro
2024-07-16
Active, closed
Follow Up of an Online Hearing Support for First-time Hearing Aid Users
NCT06468137Hearing Loss, Hearing Impairment, Hearing Disorders
Region Skane
Not applicable
100
Lund
2024-07-01
Active, closed
Lund University
Not applicable
86
Lund
2024-07-01
Recruiting
Lund University Hospital
Phase 2
33
Gothenburg, Lund, Stockholm
2024-06-20
Active, closed
Celgene
Phase 3
850
Lund, Solna, Uppsala, Linköping
2024-06-19
Recruiting
Vastra Gotaland Region
Phase 3
40
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2024-06-10
Recruiting
Immunocore Ltd
Phase 3
680
Gothenburg, Jönköping, Lund, Stockholm, Uppsala
2024-06-05
Recruiting
Lund University
Not applicable
40
Gothenburg, Jönköping, Lund, Malmö
2024-05-15
By invitation
Region Västerbotten
Not applicable
141
Lund, Umeå
2024-05-01
Recruiting
Region Örebro County
Phase 3
800
Gothenburg, Linköping, Lund, Örebro
2024-04-04
Recruiting
Mediastinal EBUS Cryobiopsy Study In Sweden
NCT06347939Mediastinal Lymphadenopathy, Lung Cancer, Sarcoidosis, Lymphoma
Region Skane
Observational
200
Lund, Umeå
2024-04-01
Recruiting
Elin Tragardh
Observational
1,500
Lund, Malmö
2024-03-29
Recruiting
Region Skane
Observational
200
Lund
2024-03-14
Recruiting
Sahar Salehi
Not applicable
475
Stockholm, Gothenburg, Linköping, Lund
2024-03-11
Recruiting
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT06217822Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression
Bayer
Phase 1
198
Lund, Stockholm, Uppsala, Gothenburg
2024-03-07
Recruiting
Lund University Hospital
Phase 3
308
Gävle, Gothenburg, Jönköping, Karlstad, Linköping, Lund, Örebro, Stockholm
2024-03-04
Recruiting
EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE
NCT07253701Epilepsy, Microbiota, Proteomics, Metabolomics
Karolinska Institutet
Observational
1,500
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2024-02-27
Recruiting
AstraZeneca
Phase 3
5,250
Gothenburg, Höllviken, Kungsbacka, Lund, Örebro, Stockholm, Umeå, Uppsala
2024-02-21
Recruiting
TeamBirth-SWE - a Care Process to Improve Safe and Person-centered Intrapartum Care
NCT06926504Person Centered Care, Patient Safety, Patient Satisfaction
Karolinska Institutet
Observational
800,000
Halmstad, Varberg, Östersund, Lund, Uppsala, Karlstad, Stockholm
2024-02-05
Recruiting
Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
NCT06710249Glioblastoma, Cerebral Metastases, Meningioma
Peter Siesjö
Phase 2
20
Lund
2024-01-27
Active, closed
Sanofi
Phase 3
260
Gothenburg, Huddinge, Lund
2024-01-23
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Lund, Umeå, Uppsala, Varberg
2024-01-22
Recruiting
Lina Bergman
Phase 3
294
Borås, Falun, Gothenburg, Linköping, Lund, Malmö, Skövde, Stockholm
2024-01-19
Recruiting
Peter Siesjö
Phase 2/3
300
Lund
2024-01-15
Recruiting
Swedish CArdioPulmonary bioImage Study 2
NCT06679777Cardiovascular Diseases, Lung Diseases
Karolinska Institutet
Observational
30,154
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2024-01-15
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugCliramitug
Alexion Pharmaceuticals, Inc.
Phase 3
1,182
Gothenburg, Lund, Skellefteå, Stockholm
2024-01-11
Recruiting
Internet-based ACT for Endometriosis and Chronic Pain
NCT06153303Endometriosis, Chronic Pain
Skane University Hospital
Not applicable
10
Lund
2024-01-01
Active, closed
The Utility of Treatment With Nasogastric Tube Placement for Small Bowel Obstruction
NCT06262815Small Bowel Obstruction, Frailty, Nasogastric Tube
Daniel Wilhelms
Observational
400
Gothenburg, Lund, Malmö, Motala, Norrköping, Sundsvall, Linköping
2024-01-01
Recruiting
Gestational Diabetes After Gastric Bypass Surgery
NCT06291766Diabetes, Gestational, Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth, or the Puerperium, Pregnancy in Diabetic, Blood Glucose Self Monitoring
Region Skane
Not applicable
120
Lund
2024-01-01
Recruiting
Anti-Glomerular Basement Membrane Disease
NCT07018024Anti-Glomerular Basement Membrane Disease
Region Skane
Observational
300
Lund
2024-01-01
Recruiting
Improving CRT Outcome With Non-Invasive Cardiac Mapping
NCT05564793Heart Failure With Reduced Ejection Fraction
EP Solutions SA
Not applicable
330
Lund, Stockholm
2023-12-20
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
DrugsElacestrant·Tamoxifen·Exemestane·Anastrozole
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Borås, Lund, Stockholm
2023-12-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Lund, Stockholm
2023-12-06
Active, closed
BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors
NCT06205706Solid Tumors, Non Small Cell Lung Cancer, Hepatocellular Carcinoma
DrugPembrolizumab
BioInvent International AB
Phase 1/2
35
Lund, Stockholm
2023-12-04
Recruiting
Vastra Gotaland Region
Phase 3
240
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2023-12-01
Recruiting
Region Skane
Not applicable
1,850
Danderyd, Eskilstuna, Falun, Gothenburg, Halmstad, Helsingborg, Lund, Malmö
2023-11-27
Not yet open
University of Dublin, Trinity College
Phase 3
952
Linköping, Lund, Örebro, Stockholm, Uppsala
2023-11
Recruiting
Hoffmann-La Roche
Phase 3
182
Lund, Uppsala
2023-10-22
Recruiting
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
NCT05879757Multiple Myeloma, Secondary Immunodeficiency (SID)
Takeda
Observational
75
Lund
2023-10-17
Active, closed
Stichting European Myeloma Network
Phase 3
759
Gothenburg, Linköping, Lund, Uppsala
2023-10-10
Active, closed
Region Skane
Observational
1,500
Helsingborg, Lund, Malmö
2023-10-01
By invitation
Standardized Osteotomy Guides for Free Flap Reconstruction of Continuous Defects of the Jaws - a Simplified Method
NCT05715359Oral Surgical Procedures, Surgery, Oral, Mandibular Reconstruction
Lund University Hospital
Observational
200
Lund
2023-10-01
Recruiting
Early Neuroprognostication After OHCA
NCT05706194Cardiac Arrest, Neurological Outcome, EEG, CT
Lund University
Observational
1,000
Helsingborg, Lund
2023-10-01
Recruiting
Region Skane
Not applicable
76
Lund, Umeå
2023-09-25
Recruiting
Cytokine Filtration in Lung Transplantation: A Swedish National Study (GLUSorb)
NCT05526950Lung Transplant Failure, Lung Transplant; Complications
Lund University Hospital
Not applicable
116
Lund
2023-09-07
Recruiting
Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer
NCT06065891Pancreas Cancer, Pancreas Adenocarcinoma, Lymph Node Metastasis
Jon Unosson
Not applicable
300
Gothenburg, Linköping, Lund, Umeå, Uppsala
2023-09-05
Recruiting
Region Skane
Observational
30
Lund
2023-09-01
Recruiting
Which Factors Are Relevant for Treatment Outcome in Dialectical Behaviour Therapy for Borderline Personality Disorder?
NCT06106555Borderline Personality Disorder, Non-suicidal Self-injury, Deliberate Self Harm
Region Skane
Observational
100
Lund
2023-09-01
Recruiting
Eva Marie Erfurth, MD, PhD
Phase 2
25
Lund
2023-09-01
Recruiting
AviadoBio Ltd
Phase 1/2
18
Lund
2023-08-30
Active, closed
Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)
NCT07579390Acute Kidney Failure, Renal Replacement Therapy for Acute Kidney Injury in ICU, Sedation in Intensive Care Unit Patients, Sedation in the ICU
Helsinki University Central Hospital
Not applicable
3,500
Gothenburg, Halmstad, Helsingborg, Karlstad, Lund, Malmö, Skövde, Stockholm
2023-08-17
Active, closed
Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation
NCT05564754Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain
Region Skane
Not applicable
3,500
Halmstad, Helsingborg, Lund, Malmö, Gothenburg, Karlstad, Skövde, Stockholm
2023-08-17
Recruiting
Aarhus University Hospital
Not applicable
400
Gothenburg, Lund, Stockholm, Umeå
2023-08-02
Recruiting
University of Helsinki
Observational
300
Lund
2023-08-01
Recruiting
Stepcare Extended Follow-up Substudy
NCT06207942Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain, Cognitive Impairment, Caregiver Burden
Region Skane
Not applicable
600
Gothenburg, Hålland, Helsingborg, Lund, Malmö
2023-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Lund, Gothenburg
2023-07-19
Active, closed
Population Health Research Institute
Not applicable
5,100
Gothenburg, Huddinge, Jönköping, Karlstad, Lund, Stockholm, Umeå, Uppsala
2023-06-22
Active, closed
Ersta Diakoni
Not applicable
150
Gothenburg, Lund, Nyköping, Stockholm, Sundsvall, Uppsala
2023-06-01
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Lund, Solna
2023-05-31
Recruiting
Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs
NCT05224401Urinary Tract Infections, Bacteremia, Antibiotic Resistant Infection
DrugTrimethoprim-sulfamethoxazole
Lund University
Phase 3
330
Helsingborg, Kristianstad, Lund, Malmö, Västerås
2023-05-29
Recruiting
Pfizer
Phase 2
100
Lund, Gothenburg, Stockholm
2023-05-17
Recruiting
Region Skane
Observational
150
Lund
2023-05-15
Active, closed
Real-time Motion Management During Prostate and Lung Radiotherapy
NCT05844761Cancer of Lung, Lung Metastasis, Cancer of Prostate
Region Skane
Not applicable
132
Lund
2023-05-01
By invitation
Novo Nordisk A/S
Observational
96
Lund
2023-04-05
Recruiting
Use of GnRHa During Chemotherapy for Fertility Protection
NCT05328258Breast Cancer Female, Acute Leukemia, Lymphoma, Osteosarcoma
DrugElacestrant
Kenny Rodriguez-Wallberg
Phase 3
500
Gothenburg, Lund, Örebro, Stockholm, Umeå
2023-03-31
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Gothenburg, Linköping, Lund, Solna, Stockholm, Uppsala, Västerås
2023-03-09
Recruiting
Region Skane
Observational
160
Helsingborg, Lund
2023-03-09
Active, closed
Bristol-Myers Squibb
Phase 3
579
Solna, Lund
2023-03-06
Recruiting
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
NCT05797519Tricuspid Regurgitation, Tricuspid Valve Disease, Tricuspid Valvular Disorders
VDyne, Inc.
Not applicable
120
Lund
2023-03-01
Recruiting
On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
NCT05755672Metastatic Colorectal Cancer, Chemotherapy Effect, Peritoneal Metastases, Liver Metastasis Colon Cancer
Region Skane
Observational
100
Lund, Malmö
2023-03-01
Recruiting
Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer
NCT05698992Esophageal Cancer, Esophageal Neoplasms, Gastric Cancer, Stomach Neoplasm
Region Skane
Observational
100
Lund
2023-02-27
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
DrugsTovorafenib·Carboplatin
Day One Biopharmaceuticals, Inc.
Phase 3
418
Gothenburg, Lund, Stockholm
2023-02-27
Recruiting
Fore Biotherapeutics
Phase 2
254
Lund, Solna
2023-02-21
Recruiting
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
NCT05679024Chronic Kidney Diseases, Atrial Fibrillation, Stroke, Intracerebral Hemorrhage
Region Stockholm
Phase 3
1,400
Falun, Östersund, Mora, Kalmar, Kalix, Lund, Malmö, Umeå
2023-02-17
Active, closed
COMPASS Pathways
Phase 3
572
Landskrona, Lund, Solna, Stockholm
2023-02-14
Active, closed
Genmab
Phase 3
900
Lund, Solna, Borås, Gothenburg, Linköping
2023-02-08
Recruiting
Lars Olaf Cardell
Phase 2/3
360
Lund, Örebro, Stockholm
2023-02-01
Recruiting
The With Or Without Olecranon K-wires Trial
NCT05657899Olecranon Fracture
Region Skane
Not applicable
200
Lund, Malmö
2023-01-01
Recruiting
Region Skane
Not applicable
88
Lund
2023-01-01
Active, closed
AstraZeneca
Phase 3
1,350
Gävle, Linköping, Lund, Stockholm, Uppsala
2022-12-29
By invitation
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
NCT05396105Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II
DrugDeucrictibant
Pharvaris Netherlands B.V.
Phase 2/3
150
Lund
2022-12-28
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2022-12-15
Active, closed
Amgen
Phase 3
7,297
Falun, Gothenburg, Helsingborg, Lund, Stockholm
2022-12-14
Recruiting
AstraZeneca
Phase 3
3,527
Helsingborg, Huddinge, Lund, Malmö, Solna, Stockholm, Umeå, Västerås
2022-12-13
Active, closed
Region Skane
Phase 1
8
Lund
2022-11-30
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Lund, Stockholm
2022-11-21
Active, closed
Ixekizumab Diabetes Intervention Trial (I-DIT)
NCT04589325Type1 Diabetes Mellitus
DrugsTaltz·Ixekizumab
Göteborg University
Phase 2
127
Borås, Falun, Gothenburg, Jönköping, Karlstad, Kristianstad, Linköping, Lund
2022-11-09
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Gothenburg, Lund, Stockholm
2022-11-08
Recruiting
Bayer
Phase 3
100
Lund, Uppsala, Stockholm - Huddinge
2022-11-08
Recruiting
Lund University Hospital
Phase 3
300
Gothenburg, Lund, Stockholm, Uppsala
2022-11-01
Active, closed
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
NCT05284747Cardiovascular Disease, Myocardial Infarction, Stroke, Coronary Revascularization
DrugsRepatha·Evolocumab
Amgen
Phase 4
6,019
Alingsås, Gävle, Jönköping, Karlskrona, Linköping, Luleå, Lund, Molndahl
2022-10-26
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Falun, Lund, Örebro, Stockholm
2022-10-25
Recruiting
Effect of Ventilation Tubes in Otitis-prone Children
NCT05348291Recurrent Acute Otitis Media
Lund University
Not applicable
150
Lund
2022-10-21
Recruiting
Region Skane
Phase 3
200
Lund
2022-09-21
Recruiting
Uppsala University
Not applicable
80
Lund, Uppsala
2022-09-01
Not yet open
A Complex Health Promotion Intervention in Parasport - The Safe & Healthy Parasport Project
NCT05317130Sport Injury, Diabetes, Health Behavior, Illness Behavior
Lund University
Observational
150
Lund
2022-09-01
Active, closed
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
DrugsNemtabrutinib·Zilovertamab vedotin
Merck Sharp & Dohme LLC
Phase 2
189
Lund, Uppsala, Gothenburg
2022-07-21
Recruiting
AstraZeneca
Phase 1/2
695
Lund, Stockholm
2022-06-24
Active, closed
DAPAgliflozin for Renal Protection in Heart Transplant Recipients
NCT05321706Heart Transplant Failure, Kidney Failure
DrugsFarxiga·Dapagliflozin
Oslo University Hospital
Phase 3
430
Lund, Stockholm
2022-06-08
Recruiting
Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
NCT05477589Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation
Vastra Gotaland Region
Phase 3
170
Gothenburg, Lund, Stockholm, Uppsala
2022-06-07
By invitation
Exercise Intervention in Patients With Heart Failure With Preserved and Reduced Ejection Fraction
NCT05255172Heart Failure New York Heart Association (NYHA) Class II, Heart Failure New York Heart Association (NYHA) Class III
Region Skane
Not applicable
120
Lund
2022-06-01
Active, closed
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755Moderate Aortic Valve Stenosis
Medtronic Cardiovascular
Not applicable
650
Lund
2022-04-27
Recruiting
OSU6162 as add-on in SSRI/SNRI-resistant Depression
NCT05641623Depression, Depressive Disorder, Treatment-Resistant, Depressive Disorder, Depressive Episode
DrugOSU6162
Göteborg University
Phase 2
180
Lund, Stockholm, Uppsala, Gothenburg
2022-04-21
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Lund, Solna
2022-04-14
Active, closed
Bayer
Phase 3
219
Lund, Stockholm - Huddinge
2022-03-28
Active, closed
Region Skane
Not applicable
288
Gothenburg, Lund, Stockholm, Umeå
2022-03-28
Active, closed
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NCT05333068Multivessel Coronary Artery Disease, Ischemia, Vulnerable Plaque, Coronary Artery Disease
Diagram B.V.
Not applicable
1,223
Linköping, Lund, Örebro, Stockholm
2022-03-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Lund, Stockholm, Umeå
2022-02-03
Recruiting
Region Skane
Not applicable
80
Lund
2022-01-01
Active, closed
Nordic Lymphoma Group
Phase 2
81
Falun, Gothenburg, Halmstad, Kalmar, Linköping, Luleå, Lund, Stockholm
2021-12-15
Active, closed
University Hospital, Basel, Switzerland
Not applicable
543
Lund
2021-12-09
Active, closed
Skane University Hospital
Not applicable
40
Lund
2021-11-26
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Stockholm, Gothenburg, Falun, Lund, Malmö, Västerås
2021-11-23
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Gothenburg, Linköping, Lund, Umeå, Uppsala
2021-11-17
Recruiting
Skane University Hospital
Not applicable
100
Lund
2021-11-15
Recruiting
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
NCT04983095Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography
Karin Soderkvist
Not applicable
118
Lund, Stockholm, Umeå, Jönköping, Örebro
2021-10-27
Recruiting
iACT for PTSD and Chronic Pain
NCT05147948Ptsd, Chronic Pain
Skane University Hospital
Not applicable
40
Lund
2021-10-18
Recruiting
Biomarkers for Ventilator-associated Pneumonia
NCT05117125Pneumonia, Ventilator-Associated
Region Skane
Observational
1,000
Lund, Malmö, Solna
2021-10-15
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Falun, Gothenburg, Helsingborg, Luleå, Lund, Umeå, Uppsala
2021-10-14
Recruiting
St George's, University of London
Not applicable
222
Lund
2021-10-08
Recruiting
Niguarda Hospital
Phase 3
288
Göthenburg, Lund, Stockholm
2021-10-07
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
DrugsBosutinib·Asciminib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 3
405
Gothenburg, Lund, Stockholm
2021-10-06
Recruiting
Pfizer
Phase 3
893
Lund, Borås, Falun, Gothenburg, Luleå, Örebro, Linköping
2021-10-04
Active, closed
Safe and Timely Antithrombotic Removal (STAR) Registry
NCT05077124Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical, Blood Loss, Postoperative
CytoSorbents, Inc
Observational
1,000
Lund
2021-09-30
Active, closed
Ole Frobert, MD, PhD
Not applicable
900
Falun, Gothenburg, Karlstad, Lund, Örebro, Västerås
2021-09-30
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Lund, Stockholm
2021-09-20
Active, closed
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer
NCT04927780Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma
DrugsLeucovorin Calcium·Fluorouracil·Irinotecan·Oxaliplatin
Erasmus Medical Center
Phase 3
378
Gothenburg, Lund, Stockholm
2021-09-07
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Gothenburg, Linköping, Lund
2021-08-19
Recruiting
Region Skane
Observational
8,000
Lund
2021-08-16
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Lund, Stockholm, Uppsala, Gothenburg
2021-08-12
Active, closed
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
NCT04754087Total Hip Arthroplasty, Degenerative Joint Disease of Hip, Avascular Necrosis of Hip, Rheumatoid Arthritis of Hip
Zimmer Biomet
Not applicable
300
Lund
2021-07-07
Active, closed
Britannia Pharmaceuticals Ltd.
Observational
312
Gothenburg, Lund, Uppsala
2021-07-06
Active, closed
AstraZeneca
Phase 3
506
Gothenburg, Lund, Uppsala
2021-06-22
By invitation
Philips Clinical & Medical Affairs Global
Not applicable
3,212
Lund, Örebro
2021-06-17
Active, closed
Novartis Pharmaceuticals
Phase 3
1,144
Gothenburg, Lund, Stockholm
2021-06-09
Recruiting
Betalactam Pharmacokinetics in Endocarditis Patients
NCT04647331Infective Endocarditis
Uppsala University
Observational
150
Gothenburg, Lund, Stockholm, Uppsala
2021-06-01
Active, closed
AstraZeneca
Phase 3
893
Lund, Solna
2021-05-10
Recruiting
Alexander Valdman
Not applicable
254
Stockholm, Gävle, Gothenburg, Linköping, Lund, Sundsvall, Umeå, Uppsala
2021-04-20
Recruiting
Lund University Hospital
Not applicable
374
Jönköping, Kalmar, Lund
2021-04-09
Recruiting
Umeå University
Not applicable
100
Gothenburg, Lund, Umeå, Uppsala
2021-04-07
Recruiting
Lund University Hospital
Observational
120
Lund
2021-04-02
Active, closed
BioNTech SE
Phase 2
327
Lund, Stockholm
2021-03-08
Active, closed
Lund University
Observational
1,964
Lund
2021-03-01
Active, closed
German CLL Study Group
Phase 3
897
Borås, Falun, Gothenburg, Halmstad, Linköping, Luleå, Lund, Örebro
2021-03-01
Recruiting
BioInvent International AB
Phase 1/2
250
Gothenburg, Lund, Stockholm
2021-01-25
Recruiting
Pfizer
Phase 3
2,100
Lund, Örebro, Stockholm
2021-01-15
Recruiting
Effect of Fetal Aortic Valvuloplasty on Outcomes
NCT05386173Congenital Heart Disease, Aortic Valve Stenosis, Fetal Cardiac Disorder, Hypoplastic Left Heart Syndrome
Queen Silvia Children's Hospital, Gothenburg, Sweden
Observational
200
Lund, Stockholm, Umeå
2021-01-01
Active, closed
ACURATE neo2™ Post Market Clinical Follow up Study
NCT04655248Aortic Valve Stenosis, Aortic Valve Calcification, Aortic Diseases
Boston Scientific Corporation
Observational
250
Lund, Stockholm
2020-12-16
Recruiting
Vastra Gotaland Region
Phase 4
1,000
Östersund, Jönköping, Trollhättan, Falun, Gothenburg, Helsingborg, Linköping, Lund
2020-12-14
Recruiting
Karolinska University Hospital
Phase 3
1,020
Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2020-11-27
Recruiting
HPV-based Screening Among Women 23-29 Years of Age
NCT05229679Human Papilloma Virus, Cervical Intraepithelial Neoplasia, Cervical Cancer
Karolinska Institutet
Not applicable
180,000
Lund, Stockholm
2020-11-16
Active, closed
Genmab
Phase 1/2
543
Borås, Gothenburg, Lund, Solna, Uppsala
2020-11-03
Recruiting
Region Skane
Not applicable
460
Lund, Malmö
2020-10-15
Active, closed
Medstar Health Research Institute
Not applicable
3,100
Gothenburg, Lund, Stockholm
2020-10-14
Recruiting
Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
NCT04183101C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality, Dense Deposit Disease
DrugEnalapril
Region Skane
Phase 2
30
Gothenburg, Lund, Stockholm, Uppsala
2020-10-01
Active, closed
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
NCT04562805Coronary Artery Disease, Ischemic Heart Disease
Elixir Medical Corporation
Not applicable
2,400
Eskilstuna, Halmstad, Helsingborg, Karlskrona, Karlstad, Lund, Malmö, Örebro
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Gothenburg, Lund, Stockholm
2020-09-17
Active, closed
AbbVie
Phase 3
330
Lund
2020-08-31
Recruiting
Nordic Lymphoma Group
Phase 3
300
Borås, Gothenburg, Halmstad, Kalmar, Linköping, Lund, Örebro, Södra Sunderbyn
2020-08-19
Active, closed
AstraZeneca
Phase 3
185
Lund
2020-08-04
Recruiting
Mats Heyman
Phase 3
6,430
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2020-07-13
By invitation
Region Skane
Not applicable
66
Lund
2020-07-01
Active, closed
Actelion
Phase 3
935
Gothenburg, Lund
2020-06-30
Recruiting
BioInvent International AB
Phase 1/2
197
Gothenburg, Lund, Stockholm
2020-06-29
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Lund, Stockholm, Uppsala
2020-06-12
Active, closed
COPE - COVID-19 in Pregnancy and Early Childhood
NCT04433364Sars-CoV2, Covid-19, Pregnancy Complications, Pregnancy Preterm
Sahlgrenska University Hospital
Observational
3,834
Falun, Halmstad, Varberg, Helsingborg, Lund, Eskilstuna, Borås, Gothenburg
2020-06-02
Active, closed
Malmö University
Phase 2/3
90
Lund, Malmö
2020-05-18
Active, closed
Åslaug Helland
Phase 2
118
Lund, Stockholm
2020-05-04
Active, closed
First in Men Study: BIOMAG-I
NCT04157153Coronary Artery Disease
Biotronik AG
Not applicable
116
Lund
2020-04-27
Recruiting
Antisecretory Factor In Severe Traumatic Brain Injury
NCT04117672Traumatic Brain Injury
Peter Siesjö
Phase 2
20
Lund
2020-03-10
Recruiting
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
NCT04722692DCIS, Breast Cancer, Breast Neoplasms, Sentinel Lymph Node
Uppsala University
Phase 3
500
Falun, Vaxjo, Lund, Västerås, Gothenburg, Uppsala, Linköping
2020-03-01
Active, closed
Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents
NCT06453590Pancreatic Cancer Non-resectable, Bile Duct Cancer, Papillary Carcinoma, Duodenal Cancer
Region Stockholm
Not applicable
450
Danderyd, Gothenburg, Karlstad, Lund, Malmö, Örebro, Skövde, Stockholm
2020-02-04
Active, closed
BeOne Medicines
Phase 3
955
Lund, Stockholm
2020-01-16
Active, closed
Actelion
Phase 3
138
Gothenburg, Lund
2020-01-16
Recruiting
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block
NCT04559425Heart Block Complete, Heart Block Second Degree
DrugDexamethasone
The Hospital for Sick Children
Observational
350
Gothenburg, Lund, Solna
2020-01-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Lund, Stockholm, Uppsala
2019-12-20
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2019-11-05
Recruiting
Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry
NCT03991728Temporomandibular Joint Disorders
AO Innovation Translation Center
Observational
200
Falun, Lund, Stockholm, Uppsala
2019-10-15
Active, closed
AstraZeneca
Phase 4
75
Gothenburg, Lund
2019-10-08
Recruiting
Combining Active and Passive DNA Hypomethylation
NCT03999723Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia
Kirsten Grønbæk
Phase 2
196
Gothenburg, Lund, Stockholm, Uppsala
2019-09-11
Active, closed
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
NCT03844048Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma
DrugsVenclexta·Venetoclax
AbbVie
Phase 3
165
Lund
2019-09-06
Recruiting
Uppsala University Hospital
Not applicable
75
Gothenburg, Lund, Örebro, Solna, Umeå, Uppsala
2019-09-01
Recruiting
Mats Heyman
Observational
500
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2019-08-29
Active, closed
Karolinska University Hospital
Observational
153
Stockholm, Gothenburg, Linköping, Lund
2019-08-29
Recruiting
University Hospital Muenster
Phase 3
683
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2019-08-23
Recruiting
Karolinska Institutet
Not applicable
20,000
Luleå, Lund, Gothenburg, Jönköping, Stockholm, Uppsala
2019-08-19
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Gothenburg, Lund, Stockholm
2019-08-12
Active, closed
Tesaro, Inc.
Phase 3
785
Linköping, Lund, Stockholm, Uppsala
2019-07-18
Active, closed
AstraZeneca
Phase 3
923
Gothenburg, Lund, Stockholm
2019-06-25
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Lund
2019-05-09
Active, closed
Long-term Exercise Effects from Robotic Walking
NCT04307602Exercise, Children, Cerebral Palsy
Lund University
Not applicable
60
Lund
2019-05-01
Recruiting
Lund University
Not applicable
70
Lund
2019-05-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Lund, Stockholm, Uppsala
2019-03-01
Active, closed
Bacteremia From Periodontal Treatment to Elucidate the Underpinnings of Sepsis
NCT04565691Bacteremia, Periodontal Diseases, Sepsis, Heart Diseases
Malmö University
Not applicable
100
Lund
2019-02-25
Recruiting
Lund University Hospital
Not applicable
100
Gävle, Gothenburg, Jönköping, Karlstad, Linköping, Lund, Örebro, Stockholm
2019-01-22
Recruiting
Lund University Hospital
Observational
2,000
Lund
2019-01-21
Active, closed
Accelerated Treatment of Endocarditis
NCT05144399Endocarditis
Herlev Hospital
Not applicable
508
Lund
2019-01-17
Active, closed
Accelerated Treatment of Endocarditis
NCT03851575Infectious Endocarditis
Copenhagen University Hospital, Rigshospitalet
Not applicable
508
Lund
2019-01-17
Active, closed
Celgene
Phase 3
363
Gothenburg, Lund, Stockholm
2019-01-02
Recruiting
Faecal Analyses in Spondyloarthritis Therapy
NCT03839862Spondyloarthropathies, Ankylosing Spondylitis
Region Skane
Observational
50
Lund
2019-01-01
Recruiting
University of Aarhus
Not applicable
750
Gothenburg, Lund, Stockholm
2019-01-01
Active, closed
Lund University Hospital
Phase 2
60
Lund, Stockholm, Vaxjo
2018-12-14
Recruiting
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
NCT03563417Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery
Aarhus University Hospital Skejby
Not applicable
1,560
Gothenburg, Lund, Stockholm
2018-11-06
Recruiting
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
NCT03646955Local Neoplasm Recurrence, Distantly Metastatic Malignant Neoplasm, Death, Fibrosis Breast
Danish Breast Cancer Cooperative Group
Not applicable
926
Gothenburg, Lund, Uppsala
2018-09-05
Recruiting
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
NCT03583710ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma
DrugsMitotane·Cis-platinum·CDDP·Platinol-AQ
M.D. Anderson Cancer Center
Phase 3
240
Gothenburg, Lund, Stockholm, Uppsala
2018-08-20
Active, closed
AbbVie
Phase 3
1,533
Lund, Gothenburg, Stockholm
2018-08-09
Active, closed
Norwegian University of Science and Technology
Phase 2
212
Gävle, Gothenburg, Linköping, Lund, Örebro, Stockholm
2018-07-31
Recruiting
The Swedish Essential Tremor (SWEET) Trial
NCT03832712Essential Tremor
Karolinska Institutet
Not applicable
100
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2018-06-30
Active, closed
Vastra Gotaland Region
Phase 4
2,201
Gothenburg, Karlskrona, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2018-06-29
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Lund, Stockholm, Uppsala
2018-06-26
By invitation
Helsinki University Central Hospital
Observational
200
Lund, Stockholm, Sundsvall, Uppsala
2018-06-01
Active, closed
Raija Silvennoinen
Phase 2
120
Borås, Gothenburg, Halmstad, Linköping, Luleå, Lund, Örebro, Skåne
2018-05-31
Recruiting
BioInvent International AB
Phase 1/2
140
Uppsala, Lund
2018-05-16
Active, closed
pharmaand GmbH
Phase 3
1,097
Linköping, Lund, Stockholm
2018-05-14
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Gothenburg, Lund, Solna, Uppsala
2018-04-11
Recruiting
Halmstad County Hospital
Observational
5,300
Alingsås, Eskilstuna, Gothenburg, Halmstad, Jönköping, Ljungby, Lund, Malmö
2018-04-01
Active, closed
Oslo University Hospital
Phase 2
53
Lund
2018-03-16
Recruiting
Jeanette Lundin
Phase 1/2
50
Falun, Gävle, Lund, Gothenburg, Örebro, Stockholm, Umeå, Uppsala
2018-02-23
Active, closed
Sanofi
Phase 3
475
Lund, Stockholm
2017-12-07
Active, closed
BeiGene
Phase 3
590
Borås, Gothenburg, Lund, Örebro, Stockholm, Uppsala
2017-10-31
Active, closed
Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation
NCT03058627Coronary Artery Disease, Aortic Valve Stenosis, TAVI, PCI
Thomas Engstrom
Not applicable
454
Gothenburg, Lund, Stockholm
2017-09-15
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Gothenburg, Lund, Stockholm
2017-09-12
Active, closed
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT03007147Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T Acute Lymphoblastic Leukemia
DrugsL-leucovorin·Therapeutic Hydrocortisone·Levofolinate·Isophosphamide
Children's Oncology Group
Phase 3
352
Lund
2017-08-08
Active, closed
University Hospital Muenster
Phase 3
650
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2017-08-03
Active, closed
Myocardial Injury in Noncardiac Surgery in Sweden
NCT03436238Perioperative/Postoperative Complications, Risk Factor, Cardiovascular
Linkoeping University
Observational
1,269
Kristianstad, Eskilstuna, Jönköping, Lund, Malmö, Norrköping, Linköping
2017-05-15
Active, closed
Karolinska Institutet
Not applicable
750
Gothenburg, Lund, Örebro, Stockholm, Uppsala
2017-05-03
Active, closed
AbbVie
Phase 3
443
Uppsala, Uddevalla, Lund, Stockholm
2017-02-02
Active, closed
BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study
NCT03049202Chronic Obstructive Pulmonary Disease, Emphysema, Chronic Bronchitis, Airway Obstruction
Karolinska Institutet
Observational
1,000
Stockholm, Gothenburg, Linköping, Lund, Umeå, Uppsala
2017-02-01
Active, closed
Oslo University Hospital
Phase 2/3
140
Gothenburg, Huddinge, Linköping, Lund, Umeå, Uppsala
2016-09
Active, closed
AGO Study Group
Not applicable
797
Lund, Solna
2016-07
Active, closed
Vastra Gotaland Region
Not applicable
74
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2016-06
Active, closed
Acerta Pharma BV
Phase 3
535
Gothenburg, Linköping, Lund, Örebro
2015-06-26
Recruiting
Centre Leon Berard
Phase 2/3
536
Lund
2015-06-02
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Huddinge, Luleå, Lund, Uddevalla
2015-03-05
Active, closed
Exelixis
Phase 4
247
Lund, Uppsala
2015-02-25
Active, closed
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer
NCT02568839Early-Stage Breast Carcinoma, HER-2 Positive Breast Cancer
DrugsTrastuzumab emtansine·Pertuzumab·Trastuzumab·Docetaxel
Thomas Hatschek
Phase 2/3
202
Örebro, Gothenburg, Lund, Stockholm, Sundsvall, Umeå, Uppsala
2014-11
Active, closed
Norwegian University of Science and Technology
Not applicable
177
Gävle, Gothenburg, Lund, Örebro, Stockholm, Umeå
2014-07-08
Active, closed
Swecrit Biobank - Blood Samples From Critically Ill Patients and Healthy Controls
NCT04974775Critical Illness, Cardiac Arrest, Sepsis, Influenza
Skane University Hospital
Observational
8,500
Helsingborg, Kristianstad, Lund, Malmö
2014-06
Recruiting
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
NCT01356290Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent, Rare CNS Tumor Recurrent
DrugsThalidomide·Celecoxib·Temozolomide·Cytarabine
Medical University of Vienna
Phase 2
232
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2014-04
Recruiting
BioMEL- Diagnostic and Prognostic Factors in Melanoma.
NCT05446155Melanoma, Melanoma in Situ, Dysplastic Nevi, Mole (Dermatology)
Region Skane
Observational
2,000
Helsingborg, Kristianstad, Lund, Malmö
2013-11-04
By invitation
An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study
NCT01460264Chronic Obstructive Pulmonary Disease, Cardiovascular Diseases, Lung Cancer
Region Skane
Observational
10,000
Lund
2013-10-16
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Gothenburg, Lund, Stockholm
2013-09-09
Active, closed
MedImmune LLC
Phase 2
571
Linköping, Lund, Umeå
2013-05-17
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Gothenburg, Lund, Stockholm, Uppsala
2013-04
Active, closed
The SCAPIS-Snus Study
NCT07573319Nicotine, Mental Health, Cardiovascular (CV) Risk, Metabolic Abnormalities
Karolinska Institutet
Observational
30,154
Gothenburg, Lund, Stockholm, Umeå, Uppsala
2013-01-01
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Not applicable
540
Lund
2012-10
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Gothenburg, Lund
2012-01
Recruiting
Lund University
Observational
20,000
Borås, Halmstad, Helsingborg, Jönköping, Karlskrona, Kristianstad, Lund, Malmö
2010-08
Active, closed
Effects of Psychiatric Admissions on Self-harm and Suicide in People With Borderline Personality Disorder
NCT06424509Borderline Personality Disorder, Self-harm, Non-suicidal Self-injury, Suicide
Lund University
Observational
390
Lund
2010-01-01
Active, closed
Karolinska University Hospital
Phase 3
2,017
Gävle, Gothenburg, Karlstad, Linköping, Lund, Malmö, Örebro, Stockholm
2007-02
Recruiting
Medtronic
Observational
20,000
Gothenburg, Lund, Skövde, Uppsala
1983-01
Rows per page Showing 1–405 of 405
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-sweden/city/lund

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,214 studies in total at the last sync on 12 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 405 of those studies with a site in Lund.

How many clinical trials are recruiting in Lund?

233 of the 405 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:17 UTC sync. A further 15 have not yet opened recruitment, 142 are active but closed to new participants, and 15 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lund), 405 studies
PhaseStudiesRecruitingShare
Phase 31447635.6%
Not applicable1046525.7%
Observational795019.5%
Phase 239209.6%
Phase 41583.7%
Phase 1/21182.7%
Phase 2/31152.7%
Phase 1210.5%

Most active sponsors

Lead sponsors with the most studies (Lund)
Lead sponsorStudiesRecruiting
Region Skane6649
Lund University2215
AstraZeneca2113
Karolinska Institutet139
Janssen Research & Development, LLC125
Lund University Hospital119
Merck Sharp & Dohme LLC104
Skane University Hospital86
Vastra Gotaland Region86
Amgen61
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.